These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 17851036

  • 1. Modeling and simulation of intravenous levetiracetam pharmacokinetic profiles in children to evaluate dose adaptation rules.
    Snoeck E, Jacqmin P, Sargentini-Maier ML, Stockis A.
    Epilepsy Res; 2007 Sep; 76(2-3):140-7. PubMed ID: 17851036
    [Abstract] [Full Text] [Related]

  • 2. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A.
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
    Chhun S, Jullien V, Rey E, Dulac O, Chiron C, Pons G.
    Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
    [Abstract] [Full Text] [Related]

  • 4. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB, Conry JA, Rodríguez-Leyva I, Gutierrez-Moctezuma J, Salas E, Coupez R, Stockis A, Lu ZS.
    Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
    Glauser TA, Mitchell WG, Weinstock A, Bebin M, Chen D, Coupez R, Stockis A, Lu ZS.
    Epilepsia; 2007 Jun; 48(6):1117-22. PubMed ID: 17442002
    [Abstract] [Full Text] [Related]

  • 6. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus.
    Uges JW, van Huizen MD, Engelsman J, Wilms EB, Touw DJ, Peeters E, Vecht CJ.
    Epilepsia; 2009 Mar; 50(3):415-21. PubMed ID: 19054418
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of levetiracetam XR 500mg tablets.
    Rouits E, Burton I, Guénolé E, Troenaru MM, Stockis A, Sargentini-Maier ML.
    Epilepsy Res; 2009 Apr; 84(2-3):224-31. PubMed ID: 19264451
    [Abstract] [Full Text] [Related]

  • 8. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.
    Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu ZS, Stockis A.
    Epilepsia; 2006 Jul; 47(7):1128-35. PubMed ID: 16886975
    [Abstract] [Full Text] [Related]

  • 9. Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients.
    Spencer DD, Jacobi J, Juenke JM, Fleck JD, Kays MB.
    Pharmacotherapy; 2011 Oct; 31(10):934-41. PubMed ID: 21950640
    [Abstract] [Full Text] [Related]

  • 10. Levetiracetam pharmacokinetics in healthy dogs following oral administration of single and multiple doses.
    Moore SA, Muñana KR, Papich MG, Nettifee-Osborne J.
    Am J Vet Res; 2010 Mar; 71(3):337-41. PubMed ID: 20187836
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of levetiracetam after oral and intravenous administration of a single dose to clinically normal cats.
    Carnes MB, Axlund TW, Boothe DM.
    Am J Vet Res; 2011 Sep; 72(9):1247-52. PubMed ID: 21879984
    [Abstract] [Full Text] [Related]

  • 12. Intravenous levetiracetam in children with seizures: a prospective safety study.
    Ng YT, Hastriter EV, Cardenas JF, Khoury EM, Chapman KE.
    J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
    [Abstract] [Full Text] [Related]

  • 13. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study.
    Wheless JW, Clarke D, Hovinga CA, Ellis M, Durmeier M, McGregor A, Perkins F.
    J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738
    [Abstract] [Full Text] [Related]

  • 14. Intravenous levetiracetam in children with epilepsy.
    Goraya JS, Khurana DS, Valencia I, Melvin JJ, Cruz M, Legido A, Kothare SV.
    Pediatr Neurol; 2008 Mar; 38(3):177-80. PubMed ID: 18279751
    [Abstract] [Full Text] [Related]

  • 15. Tolerability and dosing experience of intravenous levetiracetam in children and infants.
    Michaelides C, Thibert RL, Shapiro MJ, Kinirons P, John T, Manchharam D, Thiele EA.
    Epilepsy Res; 2008 Oct; 81(2-3):143-7. PubMed ID: 18571898
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests.
    Brockmöller J, Thomsen T, Wittstock M, Coupez R, Lochs H, Roots I.
    Clin Pharmacol Ther; 2005 Jun; 77(6):529-41. PubMed ID: 15961984
    [Abstract] [Full Text] [Related]

  • 19. Limiting cefotaxime pediatric dosing to adult standards: a pharmacokinetic simulation study.
    Dulaney Lopez AM, Rodriguez JC, Lopez-Samblas AM, Estes KS.
    Int J Clin Pharmacol Ther; 1999 Jun; 37(6):269-74. PubMed ID: 10395117
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.